Abstract:

Advances in surgical treatment of intrahepatic cholangiocarcinoma        LI Xue-chuan，WU Xiang-song，LIU Ying-bin. Department of General Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200127, China
Corresponding author：LIU Ying-bin，E-mail：laoniulyb@163.com
Abstract    Intrahepatic cholangiocarcinoma（ICC）is a malignant liver tumor second only to hepatocellular carcinoma（HCC），accounting for about 15% of its morbidity. In recent years，the global incidence of ICC is on the rise. Its progress is rapid，and it is easy to metastasize and recur，so the prognosis is poor. Radical resection（R0 resection）is still the only treatment that can cure ICC and is one of the keys to improve the prognosis of patients. At present，there are still many disputes in the surgical treatment of ICC，such as preoperative jaundice management，extent of hepatectomy，lymph node dissection，combined vascular resection，minimally invasive surgical treatment，postoperative recurrence and so on.

Key words: intrahepatic cholangiocarcinoma, radical surgery, advance

摘要： 肝内胆管癌（ICC）是发病率仅次于肝细胞肝癌的肝恶性肿瘤，约占其发病率的15%，近年来肝内胆管癌的全球发病率呈上升趋势。其进展较快，易转移复发，故预后较差。根治性手术切除（R0切除）仍是惟一可能治愈肝内胆管癌的治疗方式，是改善病人预后的关键之一。目前针对肝内胆管癌的外科治疗方面如术前黄疸的处理、肝切除范围、淋巴结清扫、联合血管切除、微创手术治疗、术后复发等仍存在很多争议。

关键词: 肝内胆管癌, 根治术, 进展